Prenatal Starting Early Program mHealth

Description

The purpose of this interventional trial is to test the efficacy of the remote delivery of the StEP:Prenatal intervention compared to standard prenatal care in pregnant individuals planning to receive prenatal and pediatric care at Bellevue Hospital. The primary aims are to determine the efficacy of the remotely delivered StEP:Prenatal intervention on diet, lifestyle behaviors, social determinants of health (SDoH), and pregnancy outcomes.

Conditions

Pregnancy

Study Overview

Study Details

Study overview

The purpose of this interventional trial is to test the efficacy of the remote delivery of the StEP:Prenatal intervention compared to standard prenatal care in pregnant individuals planning to receive prenatal and pediatric care at Bellevue Hospital. The primary aims are to determine the efficacy of the remotely delivered StEP:Prenatal intervention on diet, lifestyle behaviors, social determinants of health (SDoH), and pregnancy outcomes.

Prenatal Starting Early Program: Randomized Controlled Trial of an mHealth Intervention in Prenatal Care and Wic to Improve Nutrition and Physical Activity During Pregnancy

Prenatal Starting Early Program mHealth

Condition
Pregnancy
Intervention / Treatment

-

Contacts and Locations

New York

NYC Health + Hospitals/Bellevue, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Currently pregnant in the first trimester (up to 13 weeks, 6 days)
  • * Speak English or Spanish fluently
  • * Intent to receive prenatal and pediatric care at Bellevue
  • * ≥18 years
  • * Have a smart phone or device with internet access
  • * Willing and able to provide consent
  • * Severe illness (severe medical or mental health condition e.g. cancer, epilepsy neuromuscular disease, psychosis or bipolar disorder).
  • * Living in a shelter
  • * Receiving treatment for drug or alcohol use

Ages Eligible for Study

18 Years to 99 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

NYU Langone Health,

Mary Messito, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

2026-04-14